Scott Albert General Partner, The Aurora Funds, Inc.
Scott Albert co-founded The Aurora Funds with Jeff Clark in 1994, after already spending nearly a decade in the venture capital industry. Having also spent time as an entrepreneur, he wanted to create an Entrepreneurs-friendly venture capital firm that could offer hands on support and guidance in addition to funding. Today, he leads the IT investment team at Aurora and also oversees much of the day-to-day management of the firm, working closely with the CFO and Controller. He tries to make sure that everyone on the team does everything they can to support Aurora's portfolio companies. He personally spends more than 50% of his time helping entrepreneurs create their go-to-market strategy, raise additional funds, address customer-oriented issues and develop exit strategies. He spends the remainder of his time dealing with internal operational issues, identifying and evaluating new deals and supporting entrepreneurial efforts of the greater RTP community. Prior to forming The Aurora Funds, Scott was the Chief Investment Officer of the North Carolina Technological Development Authority, Inc. ("NCTDA"), a state funded corporation that supports technology based entrepreneurial companies in North Carolina. While there, he led the new venture investment efforts and performed portfolio company monitoring for the NCTDA's extensive statewide portfolio. Prior to serving at the NCTDA, he was at Criterion Venture Partners in Houston, Texas, as a General Partner for a $30 million pool of capital and with Golder, Thoma and Cressey, in Chicago. In addition, he has served as President of a venture-backed start-up company. Before entering the venture capital industry, he was a consultant for Booz, Allen and Hamilton. During his venture capital career, Scott has helped close more than 40 investment deals including a broad range of Information Technology and Life Science companies. Scott currently serves on the boards of several Aurora portfolio companies including ALN Medical Management, Centice, psiloQuest, StrikeIron, Trivirix, Visitar, and WiDeFi. Scott was previously on the boards of Solution Technology (acquired by Rodel) and DataFlux (acquired by SAS) and led the investment in Blackboard (NASDAQ: BBBB). Scott has a Bachelor of Science in Engineering from Duke University and a MBA from the University of Chicago.

Tom Scholl General Partner, Novak Biddle Partners
Tom Scholl is a successful entrepreneur and investor with experience sitting on both sides of the boardroom table. He has over twenty-five years experience in communications systems, equipment, chipsets and software, and has been active in the high-tech start-up scene in the Washington metro area for over 15 years. Tom currently sits on the boards of portfolio companies Centice, Paratek, Princeton Optronics, Sennari, Command Information, Fiberzone Networks and Digital Bridge. In 1990, Tom founded Telogy Networks, a leader in providing embedded communications software products for wireless and IP networks. Telogy’s award-winning products were proven market successes with world-class customers such as Cisco, Motorola, Samsung, Nortel, Alcatel and NEC. In 1998, Motorola purchased Telogy’s digital cellular technology and development team for over $40M, and in 1999, Texas Instruments purchased Telogy as the leader in embedded VOIP software for over $700M. Prior to joining Novak Biddle, Tom co-founded and became chairman of Cognio, a developer of spectrum management and MIMO technology for short-range wireless applications. In 1995, he was recognized as the Joseph A. Sciulli "Entrepreneur of the Year" by the Maryland High Technology Council. Prior to Telogy, Tom was Senior Vice President of Engineering at Hughes Network Systems, a combination of M/A-Com DCC and Linkabit. Tom is a member of the Board of Trustees at the University of Maryland and is also Chairman of the Board of Visitors at the Clark School of Engineering. Tom has patents relating to software, the Internet, and digital telephone systems, and he is the author of "Packet Switching" in McGraw Hill’s Electronic Communications Handbook. He’s a member of IEEE and ACM, and he is an alumnus of Purdue University and the Executive Management program at MIT Sloan School.

Aidar Gabidullin Oscriva Ltd
Bio Coming Soon.

Alan Levin Pharmacy Industry Veteran
Mr. Levin was formerly Chairman, President and CEO of Happy Harry’s, a leading regional drugstore chain with 2,700 employees and stores in Delaware, Maryland, Pennsylvania and New Jersey, until it was acquired by the Walgreen Company in 2006. Alan Levin is a graduate of Tulane University and the Delaware Law School of Widener University. He previously served in the Delaware Department of Justice as a Deputy Attorney General and as Executive Assistant and Counsel to United States Senator William V. Roth, Jr. He assumed the position of Chairman, President and Chief Executive Officer of Happy Harry’s, when his father and founder of the business, Harry Levin, passed away in 1987. During his tenure the company grew from 19 to 76 stores. Mr. Levin is also a past Chairman of the National Association of Chain Drug stores.

David Brady, PhD Chief Scientist of Centice Corporation and Addy Family Professor at Duke University
David Brady holds a B.A. in physics and mathematics from Macalester College and M.S. and Ph. D. degrees in applied physics from the California Institute of Technology. He was on the faculty of electrical and computer engineering at the University of Illinois in Urbana-Champaign from 1990 until joining the Duke faculty in 2001. Brady's research focuses on computational optical sensors. He leads the DISP group (www.disp.duke.edu), which builds interferometric and coherence sensors for 3D microscopy, Raman spectroscopy for biosensors, interferometric telescopy and biometric sensor networks. At the Fitzpatrick Center, Brady focuses on undergraduate and graduate education in photonics, with a particular emphasis on optics as an information science and optics education as a bridge between physical and digital systems.

Ray Swanson President & CEO of Centice Corporation
Ray W. Swanson, President and Chief Executive Officer, brings more than 20 years experience in the medical diagnostics and devices industry, with an emphasis on commercial and general management roles. Previously, Swanson was Senior Vice President of Commercial Operations for TriPath Imaging, a publicly traded cancer diagnostics and device company based in Burlington, N.C.From 1987 to 2000, Swanson held senior management positions of increasing responsibility at Dade Behring, one of the world's largest clinical diagnostics companies. Swanson was part of the team that formed Dade International through the acquisition of the diagnostic business of Baxter International Inc. in 1994. Prior to 1987, Swanson held positions with Johnson and Johnson, American Hospital Supply Corporation, Solvay Inc. and Washington University School of Medicine. Swanson has B.S. and M.S. degrees in zoology from Eastern Illinois University and an MBA from the University of Iowa.